Healthcare

The companies featured on PressReleaseFinder are active in several industries.


Clariant expands pharmaceutical-grade PEG manufacturing into North America with Texas facility

Excipient GMP-compliant manufacturing site in Clear Lake, Texas strengthens regional supply chain. 
© ClariantClariant is expanding its Clear Lake site to include excipient GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients, significantly improving their availability and reliability for North American customers, with extended reach to Latin America. The multi-phase expansion addresses critical industry priorities around supply-chain security, continuity, and responsiveness while demonstrating Clariant's long-term strategic commitment to the U.S. pharmaceutical market.

At MD&M West SABIC debuts biocompatible materials and fluoropolymer alternatives, and demonstrates rapid application development

Molded from LNP™ ELCRES™ SLX resin, Rotaid’s AED cabinet cover provides impact and UV protection. 
(Rotaid)SABIC, a global leader in the chemical industry, is showcasing at MD&M West 2026 medical-grade thermoplastics that help address performance, regulatory and production challenges. The company is exhibiting at Booth #3251 specialty materials well-suited for use in drug delivery, patient testing and surgery. SABIC is unveiling a new family of polycarbonate (PC) copolymers certified under UL746G, and new biocompatible SILTEM HU resins, which can potentially replace fluoropolymers in medical tubing. It is also illustrating its multi-prong approach to helping global customers accelerate application development through plastic design, prototyping, testing and processing services.

SABIC’s new UL746G-certified LNP ELCRES NPCRX resin can help medical device makers comply with upcoming PFAS regulations

SABIC’s new LNP™ ELCRES™ NPCRX9612U resin, the first grade in a family of polycarbonate copolymer resins formulated without fluorine or other per- and polyfluoroalkyl substances (PFAS), is well suited for applications such as insulin pumps, diagnostic imaging devices and monitors.SABIC, a global leader in the chemical industry, has introduced LNP™ ELCRES™ NPCRX9612U resin, the first grade in a family of polycarbonate copolymer resins formulated without fluorine or other per- and polyfluoroalkyl substances (PFAS). In addition to being certified under UL746G, an outline of investigation for non-fluorine and non-PFAS containing materials, the new resin delivers excellent chemical resistance to withstand harsh healthcare disinfectants, and provides UL94 V0 flame retardance at 1.5mm for thin-wall geometries. The growing NP resin portfolio, whose grade prefix indicates a UL746G-certified resin, can help manufacturers across multiple industries anticipate and adapt to increasingly stringent regulatory requirements and performance demands.

Syensqo PEEK polymer enables lightweight and precise orthopedic surgical guide through Brazilian partnership

Syensqo PEEK polymer enables lightweight and precise orthopedic surgical guide through Brazilian partnership. (Photo: Syensqo, PR098)Syensqo’s high-performance, medical-grade KetaSpire® PEEK has enabled the development of a new generation of orthopedic surgical guides made from the advanced polymer. Through a collaboration between Hanisch Medical and TechImport, two leading Brazilian health technology companies, these new guides provide surgeons with a lighter and more radiotransparent alternative to traditional metal instruments.

Syensqo’s Eviva® Polysulfone selected by BIOTRONIK for pacemaker header components

Syensqo’s Eviva® Polysulfone selected by BIOTRONIK for pacemaker header components. (Photo: Syensqo, PR102)Syensqo today announced that its Eviva® Polysulfone (PSU) has been selected by BIOTRONIK, a global leader in medical technology, for use in the header of its latest Amvia Sky pacemaker models. Eviva® PSU was chosen thanks to its outstanding biocompatibility, enabling indefinite implantation inside the human body, and its exceptional transparency, which supports precise electrode placement during surgical implantation.

Clariant celebrates Care Chemicals expansion at Daya Bay, strengthening its position in China

Clariant celebrates Care Chemicals expansion at Daya Bay, strengthening its position in China. 
© ClariantMarking a significant milestone in its Asian growth strategy, Clariant has unveiled its newly expanded state-of-the-art facilities at Daya Bay, China, following the completion of its strategic CHF 80-million investment, substantially boosts Clariant's manufacturing capabilities in one of its key growth markets.